4//SEC Filing
Taylor Andrew Lawrence 4
Accession 0001104659-23-083501
CIK 0001814114other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:12 PM ET
Size
5.4 KB
Accession
0001104659-23-083501
Insider Transaction Report
Form 4
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2023-07-20+278,363→ 278,363 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of June 6, 2023 (the "Vesting Commencement Date"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001723889
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:12 PM ET
- Size
- 5.4 KB